| Literature DB >> 33063407 |
Oleg G Salnikov1,2,3, Nikita V Chukanov2,3, Alexandra Svyatova2,3, Ivan A Trofimov2,3, Mohammad S H Kabir4, Juri G Gelovani4,5, Kirill V Kovtunov2,3, Igor V Koptyug2,3, Eduard Y Chekmenev4,6.
Abstract
Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [15 N3 ]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens of minutes) hyperpolarized state on three 15 N sites of [15 N3 ]nimorazole with T1 of up to ca. 6 minutes. The nuclear spin polarization was boosted by ca. 67000-fold at 1.4 T (corresponding to P15N of 3.2 %) by 15 N-15 N spin-relayed SABRE-SHEATH hyperpolarization technique, relying on simultaneous exchange of [15 N3 ]nimorazole and parahydrogen on polarization transfer Ir-IMes catalyst. The presented results pave the way to efficient spin-relayed SABRE-SHEATH hyperpolarization of a wide range of imidazole-based antibiotics and chemotherapeutics.Entities:
Keywords: SABRE-SHEATH; hyperpolarization; nimorazole; parahydrogen; radiosensitization
Mesh:
Substances:
Year: 2020 PMID: 33063407 PMCID: PMC7855180 DOI: 10.1002/anie.202011698
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336